Seeking Alpha

Trius Therapeutics (TSRX) announces a secondary offering, no details as to the actual size or...

Trius Therapeutics (TSRX) announces a secondary offering, no details as to the actual size or terms of the offering have been disclosed. Citigroup and Leerink Swann are acting as joint book-running managers and Baird is acting as a co-lead manager. Shares -5.5% AH.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs